The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 1, 2010, Pages 359-368

  Mantila Roosa, Sara M ^a   Kemppainen, Jessica M ^a   Moffitt, Erin N ^a   Krebsbach, Paul H ^a   Hollister, Scott J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bone tissue engineering; Micro computed tomography; Polycaprolactone; Pore size; Scaffold

Indexed keywords

BONE GROWTH; BONE MORPHOGENETIC PROTEIN-7; BONE REGENERATION; BONE TISSUE ENGINEERING; CELL MIGRATION; FIBRIN GELS; HUMAN GINGIVAL FIBROBLASTS; IMPLANTATION TIME; IN-VIVO; MASS TRANSPORT; MECHANICAL INTEGRITY; MICRO ARCHITECTURES; MICROCOMPUTED TOMOGRAPHY; PEAK STRESS; POLYCAPROLACTONE SCAFFOLDS; PORE INTERCONNECTIVITY; PORE SHAPE; SOLID FREE-FORM FABRICATION;

BIOMECHANICS; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; ENGINEERING; MECHANICAL PROPERTIES; POLYCAPROLACTONE; PORE SIZE; TISSUE ENGINEERING;

SCAFFOLDS;

FIBRIN; OSTEOGENIC PROTEIN 1; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE REGENERATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMPLANTATION; MOUSE; NONHUMAN; POROSITY; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; BONE REGENERATION; HUMANS; MECHANICAL PHENOMENA; MICE; MODELS, BIOLOGICAL; POLYESTERS; POROSITY; PROSTHESIS IMPLANTATION; STAINING AND LABELING; SUBCUTANEOUS TISSUE; TIME FACTORS; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 73549098444     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32381     Document Type: Article

References (34)

1. Campbell GR, Campbell JH. Development of tissue engineered vascular grafts. Curr Pharm Biotechnol 2007;8:43-50.
2. Chalfoun CT, Wirth GA, Evans GR. Tissue engineered nerve constructs: Where do we stand? J Cell Mol Med 2006;10:309-317.
3. Clark RA, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol 2007;127:1018-1029.
4. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007;1:245-260.
5. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Van Dyke ME, Kaplan D, Vunjak-Novakovic G. Engineering complex tissues. Tissue Eng 2006;12:3307-3339.
6. Vunjak-Novakovic G, Altman G, Horan R, Kaplan DL. Tissue engineering of ligaments. Annu Rev Biomed Eng 2004;6:131-156.
7. Hollister SJ, Lin CY, Saito E, Schek RD, Taboas JM, Williams JM, Partee B, Flanagan CL, Diggs A, Wilke EN, Van Lenthe GH, Muller R, Wirtz T, Das S, Feinberg SE, Krebsbach PH. Engineering craniofacial scaffolds. Orthod Craniofac Res 2005;8:162-173.
8. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mat Res 2001;55:203-216.
9. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-5491.
10. Lee SJ, Lee IW, Lee YM, Lee HB, Khang G. Macroporous biodegradable natural/synthetic hybrid scaffolds as small intestine submucosa impregnated poly(D,L-lactide-co-glycolide) for tissue-engineered bone. J Biomater Sci Polym Ed 2004;15:1003-1017.
11. Lin C-Y, Schek RM, Mistry AS, Shi X, Mikos AG, Krebsbach PH, Hollister SJ. Functional bone engineering using ex vivo gene therapy and topology-optimized. Biodegradable polymer composite scaffolds. Tissue Eng 2005;11:1589-1598.
12. Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, Hollister SJ, Das S. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005;26:4817-4827.
13. Shor L, Guceri S, Wen X, Gandhi M, Sun W. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 2007;28:5291-5297.
14. Zhang R, Ma PX. Poly(a-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999;44:446-455.
15. Oh SH, Park IK, Kim JM, Lee JH. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 2007;28:1664-1671.
16. Hulbert SF, Young FA, Mathews RS, Klawitter JJ, Talbert CD, Stelling FH. Potential of ceramic materials as permanently implantable skeletal prostheses. J Biomed Mater Res 1970;4:433-456.
17. Cyster L, Grant D, Howdle S, Rose F, Irvine D, Freeman D, Scotchford C, Shakesheff K. The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering. Biomaterials 2005;26:697-702.
18. Schek RM, Taboas JM, Hollister SJ, Krebsbach PH. Tissue engineering osteochondral implants for temporomandibular joint repair. Orthod Craniofac Res 2005;8:313-319.
19. Schek RM, Wilke EN, Hollister SJ, Krebsbach PH. Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials 2006;27:1160-1166.
20. Rohner D, Hutmacher DW, Cheng TK, Oberholzer M, Hammer B. In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig. J Biomed Mater Res B Appl Biomater 2003;66:574-580.
21. Causa F, Netti PA, Ambrosio L, Ciapetti G, Baldini N, Pagani S, Martini D, Giunti A. Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: In vitro characterization and human osteoblast response. J Biomed Mater Res A 2006;76:151-162.
22. Savarino L, Baldini N, Greco M, Capitani O, Pinna S, Valentini S, Lombardo B, Esposito MT, Pastore L, Ambrosio L, Battista S, Causa F, Zeppetelli S, Guarino V, Netti PA. The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 2007;28:3101-3109.
23. Venugopal J, Low S, Choon AT, Kumar AB, Ramakrishna S. Electrospun-modified nanofibrous scaffolds for the mineralization of osteoblast cells. J Biomed Mater Res A 2008;85:408-417.
24. Izquierdo R, Garcia-Giralt N, Rodriguez MT, Caceres E, Garcia SJ, Gomez Ribelles JL, Monleon M, Monllau JC, Suay J. Biodegradable PCL scaffolds with an interconnected spherical pore network for tissue engineering. J Biomed Mater Res A 2008;85:25-35.
25. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon- caprolactone) scaffolds. J Biomed Mater Res A 2003;67:1105-1114.
26. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005;26:599-609.
27. Swieszkowski W, Tuan BH, Kurzydlowski KJ, Hutmacher DW. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 2007;24:489-495.
28. Taboas JM, Maddox RD, Krebsbach PH, Hollister SJ. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 2003;24:181-194.
29. Chen Q, Kaji H, Iu M, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 2003;88:4655-4658.
30. Goulet R, Goldstein S, Ciarelli M, Kuhn J, Brown M, Feldkamp L. The relationship between the structural and orthogonal compressive properties of trabecular bone. J Biomech 1994;27:375-389.
31. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-2543.
32. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004;25:5735-5742.
33. Itala AI, Ylanen HO, Ekholm C, Karlsson KH, Aro HT. Pore diameter of more than 100 microm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res 2001;58:679-683.
34. Schek RM, Hollister SJ, Krebsbach PH. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 2004;9:130-138.